StockNews.com Initiates Coverage on Lipocine (NASDAQ:LPCN)
Equities researchers at StockNews.com assumed coverage on shares of Lipocine (NASDAQ:LPCN – Get Free Report) in a research note issued to investors on Saturday. The brokerage set a “hold” rating on the specialty pharmaceutical company’s stock. Lipocine Price Performance Shares of LPCN opened at $3.99 on Friday. The company has a market capitalization of $21.35 […]
